Tech Company Financing Transactions
Genapsys Funding Round
Genapsys secured a $75 million investment round on 2/10/2020. Investors included Oxford Finance.
Transaction Overview
Company Name
Announced On
2/10/2020
Transaction Type
Debt
Amount
$75,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to scale its global presence.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
200 Cardinal Way 3rd Floor
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
The GenapSys Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology provides a low cost, easy-to-use, fast, and accurate genome sequencing solution. We've enabled an unparalleled run cost and a simplified workflow with the first ever purely electronic sequencing chip, the key component in our fully integrated platform.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Myers
Chief Financial Officer
Britton Russell
Chief Operating Officer
Mary Stewart
Vice President
Larry Greenfield
VP - Engineering
Kosar Parizi
VP - Engineering
Hamid Rategh
VP - General Counsel
Dana Moss
VP - Human Resources
Radhika Warrier
VP - Product Management
Surekha Karudapuram
Browse more venture capital transactions:
Prev: 2/10/2020: Sonoma Biotherapeutics venture capital transaction
Next: 2/10/2020: SaaSWorks venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on tech company VC transactions. VC investment data records reported here are derived from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs